Carsten Schmeck

1.0k total citations
26 papers, 759 citations indexed

About

Carsten Schmeck is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Carsten Schmeck has authored 26 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Carsten Schmeck's work include Lipoproteins and Cardiovascular Health (5 papers), Chemical Synthesis and Analysis (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Carsten Schmeck is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Chemical Synthesis and Analysis (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Carsten Schmeck collaborates with scholars based in Germany, United States and Switzerland. Carsten Schmeck's co-authors include Andreas Kirschning, Holger Monenschein, Mario Lobell, Tobias Wunberg, Martin Hendrix, Heinrich Meier, Alexander Hillisch, Berthold Hinzen, Hartmut Beck and Louis S. Hegedus and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Carsten Schmeck

25 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Schmeck Germany 15 312 309 154 71 69 26 759
Bryan J. Witherbee United States 8 159 0.5× 326 1.1× 226 1.5× 47 0.7× 88 1.3× 9 566
Karen A. Rossi United States 19 515 1.7× 363 1.2× 129 0.8× 60 0.8× 43 0.6× 45 1.3k
Gee‐Hong Kuo United States 22 540 1.7× 486 1.6× 101 0.7× 77 1.1× 106 1.5× 46 1.0k
David R. Magnin United States 14 367 1.2× 332 1.1× 69 0.4× 85 1.2× 81 1.2× 21 736
Hiroyuki Kakinuma Japan 14 288 0.9× 325 1.1× 83 0.5× 45 0.6× 73 1.1× 43 744
Jeremy J. Edmunds United States 20 631 2.0× 427 1.4× 137 0.9× 55 0.8× 22 0.3× 54 1.1k
C. John Blankley United States 17 510 1.6× 419 1.4× 123 0.8× 90 1.3× 132 1.9× 33 1.0k
Rayomand J. Unwalla United States 19 395 1.3× 428 1.4× 219 1.4× 115 1.6× 132 1.9× 34 1.1k
Michel Souchet France 13 186 0.6× 227 0.7× 99 0.6× 48 0.7× 48 0.7× 22 514
Hans Peter Märki Switzerland 14 182 0.6× 474 1.5× 113 0.7× 105 1.5× 34 0.5× 20 734

Countries citing papers authored by Carsten Schmeck

Since Specialization
Citations

This map shows the geographic impact of Carsten Schmeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Schmeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Schmeck more than expected).

Fields of papers citing papers by Carsten Schmeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Schmeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Schmeck. The network helps show where Carsten Schmeck may publish in the future.

Co-authorship network of co-authors of Carsten Schmeck

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Schmeck. A scholar is included among the top collaborators of Carsten Schmeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Schmeck. Carsten Schmeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Unterschemmann, Kerstin, et al.. (2020). Pharmacological Inhibition of Vanin 1 Is Not Protective in Models of Acute and Chronic Kidney Disease. Journal of the American Society of Nephrology. 31(10S). 721–721. 1 indexed citations
3.
Mondritzki, Thomas, Julia Vogel, Elisabeth Pook, et al.. (2020). Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. European Journal of Heart Failure. 23(5). 743–750. 18 indexed citations
4.
Heinig, Roland, Carsten Schmeck, C. Kohlsdorfer, et al.. (2011). Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60–5521, a potent inhibitor of cholesteryl ester transfer protein. British Journal of Clinical Pharmacology. 73(2). 210–218. 16 indexed citations
5.
6.
Vakalopoulos, Alexandros, Carsten Schmeck, Hilmar Bischoff, et al.. (2010). Chromanol derivatives—A novel class of CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 488–491. 17 indexed citations
7.
Schmeck, Carsten, Heike Gielen‐Haertwig, Alexandros Vakalopoulos, et al.. (2010). Novel tetrahydrochinoline derived CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1740–1743. 19 indexed citations
8.
Weber, Olaf, et al.. (2010). Cholesteryl ester transfer protein and its inhibition. Cellular and Molecular Life Sciences. 67(18). 3139–3149. 26 indexed citations
9.
Mondritzki, Thomas, Peter Kolkhof, Hani N. Sabbah, et al.. (2010). Differentiation of Arginine Vasopressin Antagonistic Effects by Selective V2 versus Dual V2/V1a Receptor Blockade in a Preclinical Heart Failure Model. American Journal of Therapeutics. 18(1). 31–37. 14 indexed citations
10.
Haning, Helmut, Ulrich Mueller, Günter Schmidt, et al.. (2007). Novel heterocyclic thyromimetics. Part 2. Bioorganic & Medicinal Chemistry Letters. 17(14). 3992–3996. 5 indexed citations
11.
Wunberg, Tobias, Martin Hendrix, Alexander Hillisch, et al.. (2006). Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits. Drug Discovery Today. 11(3-4). 175–180. 114 indexed citations
12.
Lobell, Mario, Martin Hendrix, Berthold Hinzen, et al.. (2006). In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits. ChemMedChem. 1(11). 1229–1236. 81 indexed citations
13.
Haning, Helmut, Michael J. Woltering, Ulrich Mueller, et al.. (2005). Novel heterocyclic thyromimetics. Bioorganic & Medicinal Chemistry Letters. 15(7). 1835–1840. 12 indexed citations
14.
Brückner, David B., et al.. (2005). Dibenzodioxocinones—A new class of CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(15). 3611–3614. 34 indexed citations
15.
Kirschning, Andreas, Holger Monenschein, & Carsten Schmeck. (1999). Stabiles festphasengebundenes Iodazid. Angewandte Chemie. 111(17). 2720–2722. 24 indexed citations
16.
17.
Kirschning, Andreas, Holger Monenschein, & Carsten Schmeck. (1999). Stable Polymer-Bound Iodine Azide. Angewandte Chemie International Edition. 38(17). 2594–2596. 65 indexed citations
18.
Schmeck, Carsten & Louis S. Hegedus. (1994). Synthesis of Optically Active 4-Substituted 2-Aminobutyrolactones and Homoserines by Combined Aldol/Photocyclization Reactions of Chromium Aminocarbene Complexes. Journal of the American Chemical Society. 116(22). 9927–9934. 44 indexed citations
19.
Groth, Ulrich, et al.. (1993). Asymmetric Synthesis via Heterocyclic Intermediates, LII. Synthesis of tert‐Leucine and Related Amino Acids. Liebigs Annalen der Chemie. 1993(7). 715–719. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan J. Witherbee Breakdown of academic impact, for papers by Karen A. Rossi Breakdown of academic impact, for papers by Gee‐Hong Kuo Breakdown of academic impact, for papers by David R. Magnin Breakdown of academic impact, for papers by Hiroyuki Kakinuma Breakdown of academic impact, for papers by Jeremy J. Edmunds Breakdown of academic impact, for papers by C. John Blankley Breakdown of academic impact, for papers by Rayomand J. Unwalla Breakdown of academic impact, for papers by Michel Souchet Breakdown of academic impact, for papers by Hans Peter Märki
Rankless by CCL
2026